RecruitingNCT05500755

Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants

Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants: A Prospective Medium Term Study


Sponsor

Aula Dental Avanzada

Enrollment

150 participants

Start Date

Jul 29, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA). Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met. Clinicians need to have a "real" analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria1

  • All the patients whom received at least one DS Prime Taper implant.

Exclusion Criteria1

  • When dental implant surgery is contraindicated.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEImplant Treatment

Surgical placement of a DS Prime Taper implant and its posterior prosthesis.


Locations(1)

Clínica Dental esteve

Alicante, Alicante, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05500755


Related Trials